ZNF480 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.207400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.069800E-01
Normal-vs-Stage2
2.224000E-01
Normal-vs-Stage3
5.928000E-02
Normal-vs-Stage4
8.447200E-01
Stage1-vs-Stage2
3.240400E-01
Stage1-vs-Stage3
3.288200E-02
Stage1-vs-Stage4
6.511200E-01
Stage2-vs-Stage3
2.520600E-01
Stage2-vs-Stage4
4.572800E-01
Stage3-vs-Stage4
2.434400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.188600E-01
Normal-vs-AfricanAmerican
5.878200E-01
Normal-vs-Asian
1.710630E-01
Caucasian-vs-AfricanAmerican
3.659200E-01
Caucasian-vs-Asian
6.855000E-01
AfricanAmerican-vs-Asian
2.955000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.122800E-01
Normal-vs-Female
2.468400E-01
Male-vs-Female
7.601000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.077630E-01
Normal-vs-Age(41-60Yrs)
2.993600E-01
Normal-vs-Age(61-80Yrs)
2.290000E-01
Normal-vs-Age(81-100Yrs)
6.124200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.474600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.365000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.424800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.685200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.359600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.152800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.427940E-02
Normal-vs-Daily Drinker
2.615200E-01
Normal-vs-Weekly Drinker
2.563200E-01
Normal-vs-Occasional Drinker
6.004600E-01
Normal-vs-Social Drinker
2.040800E-01
Non Drinker-vs-Daily Drinker
2.480600E-01
Non Drinker-vs-Weekly Drinker
2.422400E-01
Non Drinker-vs-Occasional Drinker
1.736180E-02
Non Drinker-vs-Social Drinker
1.628610E-01
Daily Drinker-vs-Weekly Drinker
9.978200E-01
Daily Drinker-vs-Occasional Drinker
2.434600E-01
Daily Drinker-vs-Social Drinker
9.341600E-01
Weekly Drinker-vs-Occasional Drinker
2.894800E-01
Weekly Drinker-vs-Social Drinker
9.398800E-01
Occasional Drinker-vs-Social Drinker
2.825800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.200100E-02
Normal-vs-Grade 2
6.858500E-03
Normal-vs-Grade 3
9.635900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.200600E-01
Grade 1-vs-Grade 3
3.866000E-01
Grade 1-vs-Grade 4
5.200100E-02
Grade 2-vs-Grade 3
3.939800E-01
Grade 2-vs-Grade 4
6.858500E-03
Grade 3-vs-Grade 4
9.635900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.124370E-01
Normal-vs-NonDiabetic
1.758650E-01
Diabetic-vs-NonDiabetic
2.281800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.784400E-02
Normal-vs-NoPancreatitis
1.616230E-01
Pancreatitis-vs-NoPancreatitis
4.795400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.164760E-01
Normal-vs-N1
2.817200E-01
N0-vs-N1
2.829600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.048800E-01
Normal-vs-TP53-NonMutant
3.282600E-01
TP53-Mutant-vs-TP53-NonMutant
8.220100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
